Skip to main content
. 2020 Apr 9;9(1):1744946. doi: 10.1080/2162402X.2020.1744946

Figure 2.

Figure 2.

Analysis of CD4+ Treg and CD4+ conventional T cells (Tcon) expressing CD39 and CD73 in cancer patients. Expression of CD39 and CD73 on T cells from the peripheral blood of patients with melanoma (n = 22) or PDAC (n = 14) and of healthy donors (HD, n = 18) was analyzed by flow cytometry. (A) presents representative dot plots. Results are shown as the percentage of CD39+ or CD73+ cells among CD4+FOXP3+CD25highCD127low/- Treg (B, C) and CD4+FOXP3CD25low/-CD127high Tcon (D, E). *P < .05, ***P < .001